|
DAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44970044249726E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26730004268438E-09 |
| Normal-vs-Stage2 |
2.012900E-04 |
| Normal-vs-Stage3 |
5.01619999981884E-07 |
| Normal-vs-Stage4 |
3.06332736954573E-12 |
| Stage1-vs-Stage2 |
3.333400E-01 |
| Stage1-vs-Stage3 |
8.895000E-01 |
| Stage1-vs-Stage4 |
1.619830E-03 |
| Stage2-vs-Stage3 |
4.701200E-01 |
| Stage2-vs-Stage4 |
3.583500E-03 |
| Stage3-vs-Stage4 |
6.796800E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3989034637093E-11 |
| Normal-vs-AfricanAmerican |
7.59949999999954E-05 |
| Normal-vs-Asian |
3.8599000000028E-05 |
| Caucasian-vs-AfricanAmerican |
9.484600E-01 |
| Caucasian-vs-Asian |
1.773040E-01 |
| AfricanAmerican-vs-Asian |
3.413400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07279970965146E-10 |
| Normal-vs-Female |
3.86059995083343E-09 |
| Male-vs-Female |
6.140100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.4270999937338E-09 |
| Normal-vs-Age(41-60Yrs) |
2.96840000024723E-07 |
| Normal-vs-Age(61-80Yrs) |
9.24579968142325E-10 |
| Normal-vs-Age(81-100Yrs) |
7.907500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.095200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.679200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.379000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.634400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.666000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.987850E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.745900E-02 |
| Classical-VS-Follicular |
9.359200E-03 |
| Classical-VS-Other |
5.164400E-01 |
| Classical-VS-Normal |
7.00595137459459E-12 |
| Tall-VS-Follicular |
2.763700E-04 |
| Tall-VS-Other |
9.964600E-01 |
| Tall-VS-Normal |
4.0055736505451E-12 |
| Follicular-VS-Other |
1.936370E-01 |
| Follicular-VS-Normal |
1.140610E-03 |
| Other-VS-Normal |
7.971900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04800000000349E-06 |
| Normal-vs-N1 |
3.40280026378537E-11 |
| N0-vs-N1 |
1.136780E-03 |
|
|
